Brighton Jones’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Brighton Jones's XBI Position: Q3 2026 in Review
Brighton Jones sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 1,719 shares — an estimated $272K sold.
Brighton Jones first reported a position in XBI in Q4 2020 and held it in 3 quarters. The position peaked at $272K in Q2 2026. 959 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Brighton Jones reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 1,719 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $272K.
- Brighton Jones first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 3 quarters.
- Brighton Jones's State Street SPDR S&P Biotech ETF position peaked at $272K in Q2 2026.
- 959 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.